HFM
FBIO icon

Hartford Financial Management’s Fortress Biotech FBIO Stock Holding History

Hartford Financial Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-133
Closed -$7K – 395
2021
Q2 		$7K Hold
133
– – ﹤0.01% 315
2021
Q1 		$7K Hold
133
– – ﹤0.01% 317
2020
Q4 		$6K Hold
133
– – ﹤0.01% 308
2020
Q3 		$8K Hold
133
– – ﹤0.01% 273
2020
Q2 		$5K Hold
133
– – ﹤0.01% 296
2020
Q1 		$4K Hold
133
– – ﹤0.01% 298
2019
Q4 		$5K Hold
133
– – ﹤0.01% 314
2019
Q3 		$3K Buy
+133
New +$3.13K ﹤0.01% 335

Other funds holding FBIO

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hartford Financial Management's FBIO Position: Q3 2021 in Review

Hartford Financial Management sold out of Fortress Biotech (FBIO) in Q3 2021, closing a stake of 133 shares — an estimated $7K sold.

Hartford Financial Management first reported a position in FBIO in Q3 2019 and held it in 8 quarters. The position peaked at $8K in Q3 2020. 79 funds tracked by Wall St. Rank hold FBIO as of Q3 2021.

  • Hartford Financial Management reported no remaining Fortress Biotech position as of Q3 2021 after selling out during the quarter.
  • Hartford Financial Management sold 133 Fortress Biotech shares in Q3 2021, an estimated $7K.
  • Hartford Financial Management first reported a position in Fortress Biotech in Q3 2019 and held it in 8 quarters.
  • Hartford Financial Management's Fortress Biotech position peaked at $8K in Q3 2020.
  • 79 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2021.

Based on Hartford Financial Management's 13F filing for Q3 2021, filed 29 Oct 2021.